Mylan innovation and science
At Mylan, we have a long tradition of innovation.

From the development of complex products like biosimilars used to fight cancer and other life-threatening diseases to product formulations that can be consumed more easily by children, we’ve invested billions of dollars to more effectively reach patients with a wide variety of health conditions across 10 therapeutic categories and multiple dosage forms.

Science Around the Clock in Multiple R&D Sites Worldwide

Two global R&D centers,

including one in
West Virginia

Ten tech-focused R&D sites,

including one in Texas
and one in Vermont

>3,000

R&D, clinical, medical and regulatory professionals worldwide

>4,500

patents filed globally

~3,700

products pending approval or in development globally

Challenging the Status Quo

Mylan takes on challenges no one else will, developing innovative, cost-effective and patient-friendly treatments for diseases like cancer, diabetes, HIV/AIDS and more.

For example, lack of refrigeration once meant lack of access to certain antiretroviral (ARV) medicines for millions of HIV/AIDS patients in developing countries. Our scientists responded by making heat-stable formulations.

And Mylan's innovations go way beyond medicines. Our services and patient-support programs address a wide range of health issues.

Challenging the Status Quo

Mylan takes on challenges no one else will, developing innovative, cost-effective and patient-friendly treatments for diseases like cancer, diabetes, HIV/AIDS and more.

For example, lack of refrigeration once meant lack of access to certain antiretroviral (ARV) medicines for millions of HIV/AIDS patients in developing countries. Our scientists responded by making heat-stable formulations.

And Mylan's innovations go way beyond medicines. Our services and patient-support programs address a wide range of health issues.

Delivering Medicine the Way Patients Need It

We are committed to offering solutions that improve access and advance care for patients at every step of their healthcare journey, from prevention and diagnosis to treatment and supportive care, regardless of where they may live. Our products are capable of addressing 9 of the top 10 causes of death globally and almost 80% of the top causes of death across low- and lower-middle-income countries.1 From tablets, capsules and injectables to ointments, inhalers and transdermals, Mylan provides patients the medicine they need, the way they need it.

>7,500

Products globally

>165

Countries and territories reached including 90% of low- and lower-middle- income countries.

19¢

Average price per dose globally